Hyaluronic acid synthase mutant protein and hyaluronic acid production method using same
WO2020122430A1
Expression system for hyaluronic acid production using non-pathogenic bacteria and hyaluronic acid production method using same expression system
KR20210006161A
Processes for preparing a hydrogel patch containing loxoprofen or a pharmaceutically acceptable salt thereof
KR102185475B1
Pharmaceutical compositions for oral administration comprising irinotecan free base
KR20200142943A
Pharmaceutical compositions for oral administration in the form of powder comprising an anti-viral drug
KR20200142948A
Pharmaceutical compositions for oral administration in the form of syrup or powder comprising a water-soluble active pharmaceutical ingredient
KR20200070967A
Mutant protein of hyaluronic acid synthase and method of producing hyaluronic acid using the system
KR20200070968A
Expression system for production of hyaluronic acid by using non-pathogenic bacteria and method of preparing hyaluronic acid using the same
KR20200059495A
Oral disintegrating film formulation comprising ondansetron or its salt and process for preparing the same
KR20200021774A
Methods of manufacturing formulations comprising sitagliptin immediate release layer, and the formulations manufactured by the methods, methods of sitagliptin immediate release layer coating, and compositions for sitagliptin immediate release layer coating
KR20200018044A
A composition comprising local anesthetics and sodium polyacrylate
KR20200006682A
An oral pharmaceutical composition comprising taxane having improved oxidation stability
KR20200005110A
Methods for improving stability of pharmaceutical products containing a taxane-containing pharmaceutical composition
